药品不良反应监测工作进展分析  

Analysis of the Progress of Adverse Drug Reaction Monitoring

作　　者：李超 LI Chao(Laixi Administration for Market Regulation in Qingdao,Laixi,Shandong Province,266600 China)

机构地区：[1]山东省青岛莱西市市场监督管理局稽查大队,山东莱西266600

出　　处：《大众科学》2024年第6期77-79,共3页China Public Science

摘　　要：在新时期下,医学技术取得了高速发展,临床治疗药物也在不断增多,这对患者的治疗提供了有力支持,但也对药品不良反应(Adrerse Drag Reaction,ADR)监测工作的开展带来了较大的影响。此项工作的开展能够对药品的不良反应展开全面监测工作,充分掌握药物可能带来的不良影响,进而实现对后续药物使用的合理规范,对于患者的治疗有着重要作用。基于此,针对ADR监测工作的进展情况进行了深入分析。In the new era,medical technology has made rapid development,and clinical treatment drugs are also constantly increasing,which provides strong support for patient treatment,but also has a significant impact on the development of Adverse Drug Reaction(ADR)monitoring.The implementation of the work can comprehensively monitor adverse drug reactions,fully grasp potential adverse drug effects,and then achieve the reasonable and standardized use of subsequent drugs,which plays an important role in the treatment of patients.Based on this,the article provides an in-depth analysis of the progress of ADR monitoring.

关 键 词：药品 不良反应 监测工作 药品风险 

分 类 号：X52[环境科学与工程—环境工程]